Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis
- PMID: 1473437
- DOI: 10.1007/BF01308084
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis
Abstract
Rectal treatment with enemas, foams, and suppositories is the most efficient method of delivering an adequate quantity of locally active drugs to the distal colon. In a pilot study carried out by colonoscopy in four patients, it was observed that 4 g 5-ASA in 20 ml foam spread up or beyond the splenic flexure and more extensively than 2 g 5-ASA in 10 ml foam. Therefore we have undertaken a study in order to compare by scintigraphy the colonic distribution of 4 g 5-ASA foam versus 4 g 5-ASA in 100 ml liquid enemas in 10 patients with ulcerative colitis using a crossover randomized design. Both preparations were labeled with 100 MBq [99mTc]sulfur colloid before administration. Anterior scans were taken at intervals for 4 hr. Activity, expressed as a percentage of total radioactivity, was measured in the rectum, sigmoid, descending, transverse, and ascending colon. Six patients had the same extent of spread with the two formulations; in three patients with foam and in one patient with enema a greater spread was observed. The foam reached the upper limit of disease in all cases, while enema failed in two cases. The maximum spread with foam was observed within 30 min in nine of 10 patients compared with seven of 10 after enema. Compared to enema, foam distributes more uniformly and seems to persist longer in the descending and sigmoid colon. The 5-ASA colonic foam shows some more favorable characteristics than enema for the local treatment of left-sided ulcerative colitis.
Similar articles
-
Quantitative distribution of radiolabeled 5-aminosalicylic acid enemas in patients with left-sided ulcerative colitis.Dig Dis Sci. 1989 Nov;34(11):1792-7. doi: 10.1007/BF01540060. Dig Dis Sci. 1989. PMID: 2582990
-
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis.Aliment Pharmacol Ther. 1997 Aug;11(4):679-84. doi: 10.1046/j.1365-2036.1997.00183.x. Aliment Pharmacol Ther. 1997. PMID: 9305475 Clinical Trial.
-
Colonic spreading of a non-chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis.Aliment Pharmacol Ther. 1995 Apr;9(2):161-6. doi: 10.1111/j.1365-2036.1995.tb00365.x. Aliment Pharmacol Ther. 1995. PMID: 7605856
-
Topical salicylate therapy (4-ASA and 5-ASA enemas).Gastroenterol Clin North Am. 1989 Mar;18(1):35-42. Gastroenterol Clin North Am. 1989. PMID: 2563990 Review.
-
A mesalazine enema for ulcerative colitis.Drug Ther Bull. 1994 May 19;32(5):38-9. doi: 10.1136/dtb.1994.32538. Drug Ther Bull. 1994. PMID: 7635028 Review.
Cited by
-
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial.J Crohns Colitis. 2022 Nov 23;16(11):1714-1724. doi: 10.1093/ecco-jcc/jjac081. J Crohns Colitis. 2022. PMID: 35709376 Free PMC article. Clinical Trial.
-
Comparative tolerability of treatments for inflammatory bowel disease.Drug Saf. 2000 Nov;23(5):429-48. doi: 10.2165/00002018-200023050-00006. Drug Saf. 2000. PMID: 11085348 Review.
-
An In Situ Gelling System for the Local Treatment of Inflammatory Bowel Disease (IBD). The Loading of Maqui (Aristotelia Chilensis) Berry Extract as an Antioxidant and Anti-Inflammatory Agent.Pharmaceutics. 2019 Nov 14;11(11):611. doi: 10.3390/pharmaceutics11110611. Pharmaceutics. 2019. PMID: 31739619 Free PMC article.
-
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.World J Gastroenterol. 2011 Aug 14;17(30):3467-78. doi: 10.3748/wjg.v17.i30.3467. World J Gastroenterol. 2011. PMID: 21941413 Free PMC article.
-
Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis.Clin Exp Gastroenterol. 2014 Sep 23;7:369-83. doi: 10.2147/CEG.S35691. eCollection 2014. Clin Exp Gastroenterol. 2014. PMID: 25285021 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical